Paris, France

Thierry Voisin

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.9

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thierry Voisin: Innovator in Cancer Treatment

Introduction: Thierry Voisin is a prominent inventor based in Paris, France, known for his significant contributions to the field of pharmacology, particularly in cancer treatment. With three patents to his name, Voisin is recognized for his innovative approaches to developing therapeutic methods and compositions aimed at combating cancer.

Latest Patents: Voisin's latest inventions focus on advancing cancer therapy. One notable patent is titled "Methods and Pharmaceutical Compositions for the Treatment of Cancer," which describes a method involving the administration of at least one OX1R antagonist to patients in need of treatment. Another significant patent, "Human Monoclonal Antibodies Against Orexin Receptor Type 1," details human monoclonal antibodies targeting the orexin receptor type 1 (OX1R) for cancer treatment. These antibodies are distinguished by their unique complementary-determining regions (CDRs), with specific sequences that showcase their potential efficacy in clinical applications.

Career Highlights: Thierry Voisin has made remarkable strides in his career through his work with leading research institutions. He has been associated with the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Université Paris Diderot—Paris 7. These affiliations have provided him with a platform to collaborate and innovate within the scientific community.

Collaborations: Throughout his career, Voisin has collaborated with esteemed colleagues, including Alain Couvineau and Pascal Nicole. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion: Thierry Voisin's impact in the field of cancer research and treatment is underscored by his patents and collaborative efforts. His dedication to innovation in medicine places him among the distinguished inventors making strides toward improving patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…